PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Disease Rare Diseases 2,212 170 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Disease Gastroesophageal Reflux Disease 7,437 457 0.01 -0.97 0.06 0.55
Cancer 1,053,491 Disease Drug Acarbose (Precose)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Ancobon (Flucytosine)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Disease Sepsis 64,798 2,693 0.01 -0.98 0.04 0.55
Cancer 1,053,491 Disease Disease Hepatitis 163,842 5,739 0.01 -0.98 0.04 0.55
Cancer 1,053,491 Disease Disease Diverticulitis 4,735 323 0.00 -0.97 0.07 0.55
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Target CXCL11 526 55 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Target CXCL10 2,386 188 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target CER 2,421 197 0.00 -0.96 0.08 0.55
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Drug Actos (Pioglitazone Hydrochloride)- FDA 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Disease Gallstones 8,280 540 0.01 -0.97 0.07 0.55
Cancer 1,053,491 Disease Target D-Dimer 6,185 428 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target B2M 677 72 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target Collagenase 3 367 45 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Target Dihydrofolate Reductase 5,563 401 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target CD146 729 79 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Disease Pneumonia 81,521 3,526 0.01 -0.98 0.04 0.56
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Disease Ovarian Cyst 1,959 178 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CCL5 2,002 186 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Drug Kaempferol 2,992 258 0.00 -0.96 0.09 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Liver Disease 49,817 2,478 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Disease Thromboembolic Disease 3,336 290 0.00 -0.96 0.09 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Disease Infertility 35,448 1,911 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A3 15 4 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Disease Malnutrition 27,452 1,566 0.01 -0.97 0.06 0.56
Cancer 1,053,491 Disease Disease Secondhand Smoke 1,334 142 0.00 -0.95 0.11 0.56
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
Cancer 1,053,491 Disease Drug Drometrizole 10 3 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
Cancer 1,053,491 Disease Disease Hepatitis B 57,815 2,912 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Disease Inflammatory Bowel Diseases 4,684 400 0.01 -0.96 0.09 0.56
Cancer 1,053,491 Disease Target ACVR1B 23 6 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Target CCL2 3,560 327 0.01 -0.95 0.09 0.56
Cancer 1,053,491 Disease Drug Alemtuzumab (Campath)- FDA 32 8 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Endothelin A Receptor 722 94 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target Collapsin Response Mediator Protein-1 30 8 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Disease Myelodysplastic Syndrome 7,378 603 0.01 -0.96 0.08 0.56
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 6 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Disease Sever Condition 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Alli (Orlistat 60 mg)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Dragonamide E 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target EPHA3 140 28 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Drug Dromostanolone 8 3 0.00 -0.79 0.38 0.56
Cancer 1,053,491 Disease Drug Azacitidine (Vidaza)- FDA 47 12 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Target Buserelin 1,249 157 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Disease Arthralgia Syndrome 23 7 0.00 -0.83 0.30 0.56
Cancer 1,053,491 Disease Target CCL21 808 113 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Udp-Glucuronosyltransferase 2,219 250 0.01 -0.94 0.11 0.56
Cancer 1,053,491 Disease Disease Gallbladder Disease 1,424 178 0.00 -0.94 0.12 0.56
Cancer 1,053,491 Disease Target ERK2 3,287 347 0.01 -0.95 0.11 0.56
Cancer 1,053,491 Disease Drug Aredia (Pamidronate Disodium)- FDA 14 5 0.00 -0.80 0.36 0.56
Cancer 1,053,491 Disease Disease Infectious Diseases 33,605 2,112 0.01 -0.97 0.06 0.56
Cancer 1,053,491 Disease Disease Postgastrectomy 829 120 0.00 -0.92 0.14 0.56
Cancer 1,053,491 Disease Drug Doxorubicin Analogue 25 8 0.00 -0.82 0.32 0.56
Cancer 1,053,491 Disease Target Alpha-1 AntiChymotrypsin 1,460 188 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Drug Aloxi (Palonosetron hydrochloride)- FDA 10 4 0.00 -0.77 0.40 0.56
Cancer 1,053,491 Disease Target Retinoic Acid Receptor Alpha 1,068 149 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Drug Drimenin 4 2 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target ANGPTL4 289 55 0.00 -0.90 0.19 0.56